Clinical trials

Tools & Techniques Cell & gene therapy

Stem Cell Stepping Stones

| Roisin McGuigan

A new treatment for STAT1 mutations has a disappointingly low success rate – but shows potential.

Research Field Clinical trials

Reuse, Recycle, Regenerate

| Roisin McGuigan

Two repurposed drugs prevent neurodegeneration in mice – and both are already in clinical use.

Tools & Techniques Cancer

A Winning Combination?

| Roisin McGuigan

Engineering more effective antibody-drug conjugates.

Research Field Clinical trials

The Missing Piece of the Puzzle

| Marleen Kaatee

Marleen Kaatee explores how patients' voices can be important in medical research

Outside the Lab Clinical trials

Doing More with Less

| Raffaella Ravinetto

How can we best utilize equipment and resources in low-income regions?

Disease Area Clinical trials

Biting Back Against Malaria

| William Aryitey

A small clinical trial has shown that a malaria vaccine works in humans

Tools & Techniques Clinical trials

Into the Patient (The Art of Translation)

Translation in action, as science and engineering turns to medicine

Outside the Lab Clinical trials

See-Through Science at GSK

| Murray Stewart

Opening up our clinical trial results takes investment, but it's the right thing to do

Outside the Lab Clinical trials

The March Towards Trial Transparency

| James Cockerill

Many clinical trial results are never reported, but AllTrials hopes to change that

Tools & Techniques Animal models

Lost in Translation?

| Pascal Sanchez, Steve Finkbeiner, Kate Possin

Scientists from opposite ends of the translational spectrum have teamed up to help solve a pressing problem in Alzheimer’s research. By creating a human equivalent to the water mazes used in rodent studies, they hope to allow easier comparison of data from animal and human studies.

Register to The Translational Scientist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts

Register